TITLE

Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial

AUTHOR(S)
Andersson, Erik; Ljótsson, Brjánn; Smit, Filip; Paxling, Björn; Hedman, Erik; Lindefors, Nils; Andersson, Gerhard; Rück, Christian
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p215
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Irritable Bowel Syndrome (IBS) is highly prevalent and is associated with a substantial economic burden. Cognitive behavior therapy (CBT) has been shown to be effective in treating IBS. The aim of this study was to evaluate the cost-effectiveness of a new treatment alternative, internet-delivered CBT based on exposure and mindfulness exercises. Methods: Participants (N = 85) with IBS were recruited through self-referral and were assessed via a telephone interview and self-report measures on the internet. Participants were randomized to internet-delivered CBT or to a discussion forum. Economic data was assessed at pre-, post- and at 3-month and 1 year follow-up. Results: Significant cost reductions were found for the treatment group at $16,806 per successfully treated case. The cost reductions were mainly driven by reduced work loss in the treatment group. Results were sustained at 3-month and 1 year follow-up. Conclusions: Internet-delivered CBT appears to generate health gains in IBS treatment and is associated with costsavings from a societal perspective.
ACCESSION #
60411814

 

Related Articles

  • Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial.  // BMC Gastroenterology;2011, Vol. 11 Issue 1, p110 

    The article offers information on a study conducted by the authors related to affect and cost-effectiveness of Internet-based cognitive behavior therapy (ICBT) in treatment of irritable bowel syndrome (IBS). It states that 61 patients were randomized to 10 weeks of the therapy or a waiting list...

  • Early Life Risk Factors That Contribute to Irritable Bowel Syndrome in Adults: A Systematic Review. Chitkara, Denesh K.; van Tilburg, Miranda A. L.; Blois-Martin, Nannette; Whitehead, William E. // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p765 

    BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder that occurs in adults. The natural history of symptoms and risk factors that contribute to IBS may begin in childhood. The aim of this systematic review was to determine what early life factors contribute to the development of IBS...

  • CBT + mebeverine of value for IBS in short-term.  // PharmacoEconomics & Outcomes News;4/19/2008, Issue 551, p5 

    The article discusses research being done on using the combination of cognitive behaviour therapy and mebeverine for irritable bowel syndrome (IBS). It references a study by P. McCrone, M. Knapp et al, published in the April 2008 issue of the "European Journal of Gastroenterology and...

  • Ectopic Decidual Reaction Mimicking Irritable Bowel Syndrome: A Case Report. Salehgargari, Soraya; Sahebdel, Behrokh; Zare, Ali; Abolhassani, Hassan // Acta Medica Iranica;2014, Vol. 52 Issue 1, p88 

    Ectopic decidualization with gross involvement of the peritoneum is one of the rare findings in pregnant women particularly when ectopic decidualization disseminated as an asymptomatic intra-abdominal nodule. We present here a case of an ectopic decidualization in a 33-year-old pregnant woman...

  • Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome. Langhorst, Jost; Junge, Angela; Rueffer, Andreas; Wehkamp, Jan; Foell, Dirk; Michalsen, Andreas; Musial, Frauke; Dobos, Gustav J // American Journal of Gastroenterology;Feb2009, Vol. 104 Issue 2, p404 

    OBJECTIVES:Irritable bowel syndrome (IBS) is a highly prevalent functional disorder. According to the Rome criteria, macroscopic and histological inflammation is a crucial exclusion criterion for IBS. Human defensins appear to be part of the innate immune system in the gastrointestinal tract....

  • A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome. Mark Pimentel; Soumya Chatterjee; Christopher Chang; Kimberly Low; Yuli Song; Chengxu Liu; Walter Morales; Lemeesa Ali; Sheila Lezcano; Jeffery Conklin // Digestive Diseases & Sciences;Apr2008, Vol. 53 Issue 4, p982 

    Abstract   Rationale Two proposed hypotheses for irritable bowel syndrome (IBS) are acute gastroenteritis and bacterial overgrowth. We studied whether acute infection with Campylobacter could precipitate bacterial overgrowth in a rat model in order to link the two hypotheses....

  • α2δ ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome? Camilleri, Michael // Gut;Oct2007, Vol. 56 Issue 10, p1337 

    The article presents the author's perspective on the concept of the heteromultimeric voltage-sensitive calcium channel. This has been involved in the function of excitable tissues including sensory nerves. The author stated that pregabalin has been shown to be effective in several animal models...

  • Different segmental transit times in patients with irritable bowel syndrome and “normal” colonic transit time: is there a correlation with symptoms? Bouchoucha, M.; Devroede, G.; Dorval, E.; Faye, A.; Arhan, P.; Arsac, M. // Techniques in Coloproctology;Dec2006, Vol. 10 Issue 4, p287 

    The Rome criteria serve as gold standard for establishing a diagnosis of irritable bowel syndrome (IBS), but only represent a cluster of symptoms. On the other hand, measurement of colonic transit time (CTT) with radiopaque markers is a solid and more objective method to quantify functional...

  • Proinflammatory Cytokine Gene Polymorphisms in Irritable Bowel Syndrome. Barkhordari, Elham; Rezaei, Nima; Ansaripour, Bita; Larki, Pegah; Alighardashi, Maryam; Ahmadi-Ashtiani, Hamid Reza; Mahmoudi, Mahdi; Keramati, Mohammad-Reza; Habibollahi, Peiman; Bashashati, Mohammad; Ebrahimi-Daryani, Naser; Amirzargar, Ali Akbar // Journal of Clinical Immunology;Jan2010, Vol. 30 Issue 1, p74 

    Irritable bowel syndrome (IBS) is a multifactorial functional gastrointestinal disorder, characterized by recurrent abdominal pain and altered bowel habits. Proinflammatory cytokines can play an important role in intestinal inflammation, while their production is under genetic control. This...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics